Bromocriptine Mesylate and Daunorubicin (Liposomal)
Determining the interaction of Bromocriptine Mesylate and Daunorubicin (Liposomal) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromocriptine
Brand name: Parlodel, Cycloset
Synonyms: Bromocriptine
Generic Name: daunorubicin liposomal
Brand name: DaunoXome
Synonyms: DAUNOrubicin (Liposomal)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromocriptine Mesylate-DAUNOrubicin and Cytarabine
- Bromocriptine Mesylate-Daunorubicin and Cytarabine (Liposomal)
- Bromocriptine Mesylate-Daunorubicin and cytarabine liposome Intravenous
- Bromocriptine Mesylate-Daunorubicin citrate
- Bromocriptine Mesylate-Daunorubicin citrate liposome Intravenous
- Bromocriptine Mesylate-Daunorubicin hydrochloride
- Daunorubicin (Liposomal)-Brompheniramine
- Daunorubicin (Liposomal)-Brompheniramine and codeine
- Daunorubicin (Liposomal)-Brompheniramine and phenylephrine
- Daunorubicin (Liposomal)-Brompheniramine and Phenylephrine Chewable Tablets
- Daunorubicin (Liposomal)-Brompheniramine and Phenylephrine Liquid
- Daunorubicin (Liposomal)-Brompheniramine and Phenylephrine Suspension